Longitudinal Dynamics of AT1R Antibodies in Kidney Transplant Recipients

This study aims to investigate the dynamics of Angiotensin II Type 1 Receptor Antibodies (AT1R-Ab) before and after kidney transplantation. The purpose is to understand how changes in AT1R-Ab levels may impact post-transplant kidney function and graft survival. Participants will include kidney transplant recipients, and their AT1R-Ab levels will be monitored over a one-year period. This research may help develop better predictive models for transplant outcomes, improving clinical decision-making for transplant physicians.

NCT Number	NCT07374484
Lead Sponsor	Seoul National University Hospital Collaborators: Ministry of Health, Republic of Korea
Conditions	Kidney Transplantation, Graft Survival, Angiotensin II Type 1 Receptor Antibody
Enrollment	241 participants
Start Date	2024-12-10
Primary Completion	2025-10-20 (estimated)
Study Completion	2025-12-09 (estimated)
Updated on ClinicalTrials.gov	2026-01-28